Health TrialsbyHealthPanel

Plasma Cell Neoplasms

2

Review clinical trials related to Plasma Cell Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

This study aims to assess the safety profile of in vivo BCMA/GPRC5D-targeted CAR-T cell immunotherapy in patients with relapsed or refractory plasma cell neoplasms.

Participants needed: 18
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Liping DouUpdated: Oct 2, 2026Locations: 1
Eligibility criteria

Voluntary signing of informed consent by the subject or legally authorized repre... [+11]

Severe cardiac dysfunction with left ventricular ejection fraction (LVEF) < 50%. [+10]

Read more
Status: Recruiting

Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma

A multicenter, non-interventional, observational, retrospective and prospective pharmacological study aimed at evaluating the use of allogeneic hematopoietic stem cell transplantation in patients with relapsed/refractory multiple myeloma.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Università degli Studi 'G. d'Annunzio' Chieti e PescaraUpdated: Aug 20, 2026Locations: 1Duration: 24 Months
Eligibility criteria

patients diagnosed with relapsed/refractory multiple myeloma according to IMWG c... [+2]

Patients diagnosed with primary AL amyloidosis, monoclonal gammopathy of undeter... [+2]

Read more